M. Alexander Otto began his reporting career early in 1999 covering the pharmaceutical industry for a national pharmacists' magazine and freelancing for the Washington Post and other newspapers. He then joined BNA, now part of Bloomberg News, covering health law and the protection of people and animals in medical research. Alex next worked for the McClatchy Company. Based on his work, Alex won a year-long Knight Science Journalism Fellowship to MIT in 2008-2009. He joined the company shortly thereafter. Alex has a newspaper journalism degree from Syracuse (N.Y.) University and a master's degree in medical science -- a physician assistant degree -- from George Washington University. Alex is based in Seattle.
News
Case series suggests biologics, JAK inhibitors safe during pandemic
Investigators saw no increase in hospitalizations versus the general population in New York City.
News
Yale’s COVID-19 inpatient protocol: Hydroxychloroquine plus/minus tocilizumab
Yale cardiologist offers lessons from “the haze of battle” on fighting COVID-19 with little evidence.
News
Evidence on spironolactone safety, COVID-19 reassuring for acne patients
Observations in Spain – increased prevalence of androgenic alopecia among hospitalized patients – support the androgen link.
News
Six million childhood cancer deaths could be prevented over the next 30 years
Researchers propose taking actions that could greatly reduce global childhood cancer deaths.
News
Protean manifestations of COVID-19: “Our ignorance is profound”
“Make sure they didn’t die in vain.”
News
COVID-19 PPE-related skin effects described in survey of Chinese doctors, nurses
Almost 75% of doctors and nurses in and around Wuhan, China, reported skin problems during a single week in early February.
News
Cardiology groups push back on hydroxychloroquine, azithromycin for COVID-19
Both drugs are known to cause torsade de pointes and increase the risk of other arrhythmias, say the AHA, ACC, and HRS.
News
NCCN panel: Defer nonurgent skin cancer care during pandemic
The group’s melanoma recommendations focused on deferring nonurgent care until after the pandemic passes.
News
Rethink urologic cancer treatment in the era of COVID-19
Prioritize regimens “with a clear survival advantage,” but many treatments can be stopped or delayed, editorialists say.
News
FDA grants emergency authorization for first rapid antibody test for COVID-19
Labeling for the new antibody test indicates that the results should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection.
News
Skin manifestations are emerging in the coronavirus pandemic
“COVID-19 can feature signs of small blood vessel occlusion. These can be petechiae or tiny bruises, and transient lividoid eruptions.”
News
Vascular biomarkers predict pulmonary hypertension in systemic sclerosis
But it was “a major fishing expedition.”
News
AASLD: Liver transplants should proceed despite COVID-19
Immunosuppression may be protective; the advice comes from a document a recently released from AASLD to help hepatologists and liver transplant...